Your browser doesn't support javascript.
loading
Protocol for generation of 3D bone marrow surrogate microenvironments in a rotary cell culture system.
Belloni, Daniela; Ferrarini, Marina; Ferrero, Elisabetta; Guzzeloni, Virginia; Barbaglio, Federica; Ghia, Paolo; Scielzo, Cristina.
Afiliação
  • Belloni D; B Cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, 20123 Milan, Italy; Università Vita Salute San Raffaele, 20123 Milan, Italy; Unit of Malignant B Cells Biology and 3D Modelling, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, 20123 Milan, Italy.
  • Ferrarini M; B Cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, 20123 Milan, Italy.
  • Ferrero E; B Cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, 20123 Milan, Italy.
  • Guzzeloni V; B Cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, 20123 Milan, Italy.
  • Barbaglio F; Unit of Malignant B Cells Biology and 3D Modelling, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, 20123 Milan, Italy.
  • Ghia P; B Cell Neoplasia Unit, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, 20123 Milan, Italy; Università Vita Salute San Raffaele, 20123 Milan, Italy; Strategic Research Program on CLL, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, 20123 Milan, Italy.
  • Scielzo C; Unit of Malignant B Cells Biology and 3D Modelling, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, 20123 Milan, Italy. Electronic address: scielzo.cristina@hsr.it.
STAR Protoc ; 3(3): 101601, 2022 09 16.
Article em En | MEDLINE | ID: mdl-35990738
ABSTRACT
In this protocol, we describe how to generate 3D culture surrogates of chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) bone marrow microenvironments. We detail the use of culturing scaffolds populated with BM stromal cells and tumor cells in the RCCS™ bioreactor. This 3D culture can efficiently recapitulate tumor-stroma crosstalk and allows the testing of drugs such as ibrutinib and bortezomib. Moreover, this protocol can be used for the generation of other and more complex tumor microenvironments. For complete details on the use and execution of this protocol, please refer to Belloni et al. (2018) and Barbaglio et al. (2021).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medula Óssea / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article